Related Posts
St. Vincent de Paul Charitable Pharmacy offers article regarding impact of a charitable pharmacy on their community and patients
We estimate that if the PHE expires in April 2023, 18.0 million people will lose Medicaid coverage in the following…
The Outcomes of Implementing and Integrating Comprehensive Medication Management in Team-Based Care: A Review of the Evidence on Quality, Access and Costs, December 2023
One in four Americans say they struggle to afford their prescription medications. The establishment of this Charitable Pharmacy in Milford will allow patients who live east of Cincinnati better access to care.
Charitable Pharmacies of America organization member receives Health Equity grant
Medication non-adherence has led to at least 100,000 preventable deaths each year and $100 billion annually in preventable healthcare costs in the United States
NOVA ScriptsCentral is excited to collaborate with the American Pharmacist Association to launch the “NOVA ScriptsCentral & American Pharmacist Association Safety-Net Health Equity Fellowship”.
‘Unbelievably good price’: KC-area pharmacy dispenses bargain medicine — and hope Go to article
Charitable Pharmacies of America organization member receives Health Equity grant
Recent federal legislative and regulatory updates in managed care pharmacy have prioritized topics ranging from expedited access to novel therapeutics to the health disparities and equity concerns affecting patient populations nationwide, but progress on these developments will depend on the impact of the midterm elections
How a ‘weighted lottery’ helped underserved patients get a scarce Covid drug
The five most recent states to expand the scope of reimbursement for pharmacists are Maryland, Missouri, North Dakota, Virginia and Wyoming
Using Public Health Detailing to Increase Access and Confidence in COVID-19 Vaccines and Reinvest in Disproportionately Impacted NYC Communities Go…
How is a charitable pharmacy different from other types of pharmacies?
NABP Associate Executive Director Josh Bolin on DSCSA compliance prior to FDA moving compliance deadline.

